|
ENO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84050552576309E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76458847533922E-12 |
| Normal-vs-Stage2 |
7.799500E-04 |
| Normal-vs-Stage3 |
1.62370000000855E-06 |
| Normal-vs-Stage4 |
2.05699999999975E-05 |
| Stage1-vs-Stage2 |
3.011700E-02 |
| Stage1-vs-Stage3 |
1.657750E-02 |
| Stage1-vs-Stage4 |
3.190100E-02 |
| Stage2-vs-Stage3 |
7.143800E-01 |
| Stage2-vs-Stage4 |
7.417000E-01 |
| Stage3-vs-Stage4 |
9.751400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88929982769537E-11 |
| Normal-vs-AfricanAmerican |
3.200200E-04 |
| Normal-vs-Asian |
4.579500E-02 |
| Caucasian-vs-AfricanAmerican |
6.430400E-01 |
| Caucasian-vs-Asian |
6.318200E-01 |
| AfricanAmerican-vs-Asian |
8.069800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22740000385591E-08 |
| Normal-vs-Female |
4.82947015711943E-14 |
| Male-vs-Female |
2.561900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.576500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.20029583231485E-11 |
| Normal-vs-Age(61-80Yrs) |
4.47490045019094E-10 |
| Normal-vs-Age(81-100Yrs) |
1.187670E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.103000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.205200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.311600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.200600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.049200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.432400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.79109995910454E-09 |
| Normal-vs-Grade 2 |
1.75071068753141E-12 |
| Normal-vs-Grade 3 |
2.00659999727293E-08 |
| Normal-vs-Grade 4 |
4.375300E-04 |
| Grade 1-vs-Grade 2 |
6.618100E-02 |
| Grade 1-vs-Grade 3 |
3.684100E-03 |
| Grade 1-vs-Grade 4 |
1.462790E-03 |
| Grade 2-vs-Grade 3 |
8.516800E-03 |
| Grade 2-vs-Grade 4 |
4.217200E-03 |
| Grade 3-vs-Grade 4 |
2.985400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.582500E-03 |
| ccA subtype-vs-ccB subtype |
1.10467190950203E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.8005000519733E-09 |
| Normal-vs-N1 |
8.665900E-02 |
| N0-vs-N1 |
8.031800E-01 |
|
|
